BNTC Stock Summary and Trading Ideas (Benitec Biopharma | NASDAQ:BNTC)

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Benitec Biopharma trades on the NASDAQ stock market under the symbol BNTC.

As of April 16, 2026, BNTC stock price declined to $13.46 with 117,639 million shares trading.

BNTC has a beta of 0.80, meaning it tends to be less sensitive to market movements. BNTC has a correlation of 0.04 to the broad based SPY ETF.

BNTC has a market cap of $462.41 million. This is considered a Small Cap stock.

In the last 3 years, BNTC traded as high as $17.15 and as low as $1.86.

The top ETF exchange traded funds that BNTC belongs to (by Net Assets): PINK, VTI, IWM, VXF, IWO.

BNTC has underperformed the market in the last year with a return of -1.6%, while SPY returned +31.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BNTC shares. However, BNTC has outperformed the market in the last 3 month and 2 week periods, returning +14.9% and +22.7%, while SPY returned +1.6% and +7.1%, respectively. This indicates BNTC has been having a stronger performance recently.

BNTC support price is $12.99 and resistance is $14.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BNTC shares will trade within this expected range on the day.